Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest Update

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totalling 56,500 shares, a growth of 228.5% from the September 30th total of 17,200 shares. Based on an average daily volume of 58,800 shares, the short-interest ratio is currently 1.0 days.

Fresenius SE & Co. KGaA Price Performance

FSNUY stock traded down $0.03 during mid-day trading on Friday, hitting $9.11. 25,057 shares of the stock were exchanged, compared to its average volume of 27,428. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.29 and a quick ratio of 1.00. The stock has a market capitalization of $20.34 billion, a price-to-earnings ratio of 12.24 and a beta of 1.05. The business has a fifty day moving average price of $9.28 and a 200 day moving average price of $8.38. Fresenius SE & Co. KGaA has a 12 month low of $6.33 and a 12 month high of $9.78.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last released its earnings results on Wednesday, July 31st. The company reported $0.22 earnings per share for the quarter. The firm had revenue of $5.83 billion during the quarter. On average, sell-side analysts anticipate that Fresenius SE & Co. KGaA will post 0.84 EPS for the current year.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.